Combination therapy with alpha-lipoic acid (ALA), gliclazide, and ramipril has been shown to prevent the onset of DCM by inhibiting the TGF-β1/Smad pathway [231]. The gene discussed is TGFB1; the disease is familial dilated cardiomyopathy.